Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Double-Blind Randomized Study to Evaluate Safety and Efficacy of Interferon Beta-1a (Avonex) Plus Simvastatin (Zocor) Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis Over a One Year Period

NCT00146068 is registered in ClinicalTrials.gov with University of North Carolina as lead sponsor.

NCT NCT00146068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00146068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Double-Blind Randomized Study to Evaluate Safety and Efficacy of Interferon Beta-1a (Avonex) Plus Simvastatin (Zocor) Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis Over a One Year Period
Lead sponsor
University of North Carolina
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2004
Completion date
December 31, 2007
Enrollment
30
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis